IRIS Accounts Production v26.1.10.61 09170106 director 1.1.25 31.12.25 31.12.25 30.6.26 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091701062024-12-31091701062025-12-31091701062025-01-012025-12-31091701062023-12-31091701062024-01-012024-12-31091701062024-12-3109170106ns15:EnglandWales2025-01-012025-12-3109170106ns14:PoundSterling2025-01-012025-12-3109170106ns10:Director12025-01-012025-12-3109170106ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3109170106ns10:SmallEntities2025-01-012025-12-3109170106ns10:Audited2025-01-012025-12-3109170106ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3109170106ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109170106ns10:FullAccounts2025-01-012025-12-3109170106ns10:CompanySecretary12025-01-012025-12-3109170106ns10:RegisteredOffice2025-01-012025-12-3109170106ns5:CurrentFinancialInstruments2025-12-3109170106ns5:CurrentFinancialInstruments2024-12-3109170106ns5:ShareCapital2025-12-3109170106ns5:ShareCapital2024-12-3109170106ns5:RetainedEarningsAccumulatedLosses2025-12-3109170106ns5:RetainedEarningsAccumulatedLosses2024-12-3109170106ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3109170106ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31
REGISTERED NUMBER: 09170106 (England and Wales)















Financial Statements for the Year Ended 31 December 2025

for

Hemodia UK Ltd

Hemodia UK Ltd (Registered number: 09170106)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Hemodia UK Ltd

Company Information
for the Year Ended 31 December 2025







DIRECTOR: R Teuliere





SECRETARY: Pramex International Ltd





REGISTERED OFFICE: Pramex International Ltd
11 Old Jewry
London
United Kingdom
EC2R 8DU





REGISTERED NUMBER: 09170106 (England and Wales)





AUDITORS: HB Accountants
Plumpton House
Plumpton Road
Hoddesdon
Herts
EN11 0LB

Hemodia UK Ltd (Registered number: 09170106)

Balance Sheet
31 December 2025

31.12.25 31.12.24
Notes £ £
CURRENT ASSETS
Debtors 4 516,172 454,331
Cash at bank 69,337 62,320
585,509 516,651
CREDITORS
Amounts falling due within one year 5 100,588 89,514
NET CURRENT ASSETS 484,921 427,137
TOTAL ASSETS LESS CURRENT
LIABILITIES

484,921

427,137

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 483,921 426,137
484,921 427,137

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 June 2026 and were signed by:





R Teuliere - Director


Hemodia UK Ltd (Registered number: 09170106)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Hemodia UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention and amounts are rounded to the nearest £.

Turnover
Turnover represents amounts receivable, under contracts for services, net of Value Added Tax. Turnover is recognised to the extent that there is a right to consideration and is recorded at the value of the consideration due. Where a contract has only been partially completed at the balance sheet date turnover represents the value of the service provided to date based on a proportion of the total expected consideration at completion. Where payments are received from customers in advance of services provided, the amounts are recorded as 'deferred income' and included as part of Creditors due within one year.

Hemodia UK Ltd (Registered number: 09170106)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade debtors, loans and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including trade creditors, unpaid pension contributions, taxation, accruals, deferred income and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.


Hemodia UK Ltd (Registered number: 09170106)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 2 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£ £
Trade debtors 117,695 130,039
Amounts owed from group
undertakings

391,831

318,155
Employee advances 3,000 3,000
Accrued income and prepayments 3,646 3,137
516,172 454,331

Hemodia UK Ltd (Registered number: 09170106)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£ £
Trade creditors 917 2,254
Amounts owed to group undertakings 46,839 43,908
Tax 19,233 8,788
Social security and other taxes 1,055 956
VAT 19,318 20,366
Pensions 338 338
Accruals 12,888 12,904
100,588 89,514

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Karen Chase (Senior Statutory Auditor)
for and on behalf of HB Accountants

7. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

8. PARENT COMPANY

The company's immediate parent company is Hemodia SAS, a company registered in France. The ultimate parent company is Financiere Hemodia SAS.

The smallest and largest group for which accounts are prepared and of which the company is a member is Financiere Hemodia SAS. Copies of the consolidated accounts can be obtained from its registered office 104 Rue du Chene Vert, 31670 Labege, France.